AMCB Exam Questions With Correct
Answers
Hyperlipidemia - CORRECT ANSWER✔✔-LDL >/= 190 mg/dL
| | | | | |
Anemia - CORRECT ANSWER✔✔-Hgb<11 (1st tri), 10.5 (2nd tri), 11 (3rd tri), or
| | | | | | | | | | | | |
<12 (non-pregnant)
|
Iron deficiency anemia - CORRECT ANSWER✔✔-Hgb<12 and serum ferritin<100-
| | | | | | | |
150mg/dL
Iron RDA - CORRECT ANSWER✔✔-15mg (teen), 18mg (adult), 8mg
| | | | | | | | |
(postmenopausal), 27mg (pregnant), 9mg (lactation) | | | |
Rhinosinusitis treatment - CORRECT ANSWER✔✔-Augmentin or Doxycycline, if
| | | | | | | |
bacterial origin |
Pharyngitis treatment - CORRECT ANSWER✔✔-Penicillin and amoxicillin, if
| | | | | | | |
bacterial origin (first-ten cephalosporins if PCN allergic)
| | | | | |
Pertussis treatment - CORRECT ANSWER✔✔-Erythromycin, Azithromycin,
| | | | | |
Clarithromycin, or Bactrim; including close contacts and exposed individuals at
| | | | | | | | | |
risk for severe disease (3rd tri)
| | | | |
, Intermittent Asthma - CORRECT ANSWER✔✔-Symptoms <2d/wk, nighttime
| | | | | | |
symptoms <2x/mo, no ADL interference, and </= 1 exacerbation/yr
| | | | | | | |
Tx with SABA (Albuterol) PRN
| | | |
Intermittent Asthma Treatment - CORRECT ANSWER✔✔-SABA PRN (Albuterol)
| | | | | | |
Symptoms <2x/wk and nighttime <2x/mo
| | | |
Persistent Mild Asthma - CORRECT ANSWER✔✔-Symptoms >2x/wk and
| | | | | | | |
>2nights/mo, and minor ADL interference
| | | |
Tx with low dose ICS (Fluticasone, Budesonide) and SABA (Albuterol) PRN
| | | | | | | | | |
Persistent Mild Asthma Treatment - CORRECT ANSWER✔✔-Low-dose ICS
| | | | | | | |
(Fluticasone, Budesonide), and SABA (Albuterol) PRN
| | | | |
Persistent Moderate Asthma - CORRECT ANSWER✔✔-Daily symptoms, and
| | | | | | |
>1x/wk but not nightly, some ADL interference
| | | | | | |
Tx with Low-dose ICS (Fluticasone, Budesonide) and LABA (Formoterol,
| | | | | | | | |
Salmeterol)--Combos: Symbicort, Advair (and PRN SABA-Albuterol) | | | | |
Persistent Moderate Asthma Treatment - CORRECT ANSWER✔✔-Low-dose ICS
| | | | | | | |
(Fluticasone, Budesonide) -and- | | |
Answers
Hyperlipidemia - CORRECT ANSWER✔✔-LDL >/= 190 mg/dL
| | | | | |
Anemia - CORRECT ANSWER✔✔-Hgb<11 (1st tri), 10.5 (2nd tri), 11 (3rd tri), or
| | | | | | | | | | | | |
<12 (non-pregnant)
|
Iron deficiency anemia - CORRECT ANSWER✔✔-Hgb<12 and serum ferritin<100-
| | | | | | | |
150mg/dL
Iron RDA - CORRECT ANSWER✔✔-15mg (teen), 18mg (adult), 8mg
| | | | | | | | |
(postmenopausal), 27mg (pregnant), 9mg (lactation) | | | |
Rhinosinusitis treatment - CORRECT ANSWER✔✔-Augmentin or Doxycycline, if
| | | | | | | |
bacterial origin |
Pharyngitis treatment - CORRECT ANSWER✔✔-Penicillin and amoxicillin, if
| | | | | | | |
bacterial origin (first-ten cephalosporins if PCN allergic)
| | | | | |
Pertussis treatment - CORRECT ANSWER✔✔-Erythromycin, Azithromycin,
| | | | | |
Clarithromycin, or Bactrim; including close contacts and exposed individuals at
| | | | | | | | | |
risk for severe disease (3rd tri)
| | | | |
, Intermittent Asthma - CORRECT ANSWER✔✔-Symptoms <2d/wk, nighttime
| | | | | | |
symptoms <2x/mo, no ADL interference, and </= 1 exacerbation/yr
| | | | | | | |
Tx with SABA (Albuterol) PRN
| | | |
Intermittent Asthma Treatment - CORRECT ANSWER✔✔-SABA PRN (Albuterol)
| | | | | | |
Symptoms <2x/wk and nighttime <2x/mo
| | | |
Persistent Mild Asthma - CORRECT ANSWER✔✔-Symptoms >2x/wk and
| | | | | | | |
>2nights/mo, and minor ADL interference
| | | |
Tx with low dose ICS (Fluticasone, Budesonide) and SABA (Albuterol) PRN
| | | | | | | | | |
Persistent Mild Asthma Treatment - CORRECT ANSWER✔✔-Low-dose ICS
| | | | | | | |
(Fluticasone, Budesonide), and SABA (Albuterol) PRN
| | | | |
Persistent Moderate Asthma - CORRECT ANSWER✔✔-Daily symptoms, and
| | | | | | |
>1x/wk but not nightly, some ADL interference
| | | | | | |
Tx with Low-dose ICS (Fluticasone, Budesonide) and LABA (Formoterol,
| | | | | | | | |
Salmeterol)--Combos: Symbicort, Advair (and PRN SABA-Albuterol) | | | | |
Persistent Moderate Asthma Treatment - CORRECT ANSWER✔✔-Low-dose ICS
| | | | | | | |
(Fluticasone, Budesonide) -and- | | |
